Výsledky vyhledávání

Akademický článek

Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function.

Autor: Mörtberg J; Centre for Clinical Research, Vastmanland Hospital Vasteras, Region Vastmanland - Uppsala University, Sweden; Division of Nephrology, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden. Electronic address: josefin.mortberg@regionvastmanland.se., Salzinger B; Division of Nephrology, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden., Lundwall K; Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden., Edfors R; Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden., Jacobson SH; Division of Nephrology, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden., Wallén HN; Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden., Jernberg T; Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden., Baron T; Department of Medical Sciences, Cardiology, Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden., Erlinge D; Department of Cardiology, Clinical Sciences, Lund University, Lund, Sweden., Andell P; Unit of Cardiology, Department of Medicine, Karolinska Institutet, Heart and Vascular Division, Karolinska University Hospital, Stockholm, Sweden., James S; Department of Medical Sciences, Cardiology, Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden., Eggers KM; Department of Medical Sciences, Cardiology, Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden., Hjort M; Department of Medical Sciences, Cardiology, Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden., Kahan T; Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden., Lundman P; Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden., Tornvall P; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden., Rezeli M; Clinical Protein Science & Imaging, Department of Biomedical Engineering, Lund University, BMC D13, Lund SE-221 84, Sweden., Marko-Varga G; Clinical Protein Science & Imaging, Department of Biomedical Engineering, Lund University, BMC D13, Lund SE-221 84, Sweden., Lindahl B; Department of Medical Sciences, Cardiology, Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden., Spaak J; Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.

Publikováno v: International journal of cardiology [Int J Cardiol] 2023 Feb 15; Vol. 373, pp. 64-71. Date of Electronic Publication: 2022 Dec 05.

Zobrazit plný text záznamu

Akademický článek

Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries.

Autor: Svenungsson E; Department of Medicine, Solna, Division of Rheumatology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden., Spaak J; Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine, Karolinska Institutet, Stockholm, Sweden., Strandberg K; Department of Clinical Chemistry and Pharmacology, Division of Laboratory Medicine, Coagulation Laboratory Malmö, University and Regional Laboratories, Region Skåne, Sweden., Wallén HN; Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine, Karolinska Institutet, Stockholm, Sweden., Agewall S; Department of Cardiology, Oslo University Hospital and Institute of Clinical Sciences, Oslo University Hospital, University of Oslo, Oslo, Norway., Brolin EB; Department of Clinical Science, Intervention and Technology, Karolinska Institutet and Department of Radiology, Capio S:t Göran's Hospital, Stockholm, Sweden., Collste O; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden., Daniel M; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden., Ekenbäck C; Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine, Karolinska Institutet, Stockholm, Sweden., Frick M; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden., Henareh L; Department of Medicine, Heart and Vascular Theme, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden., Malmqvist K; Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine, Karolinska Institutet, Stockholm, Sweden., Elvin K; Department of Medicine Solna, Division of Immunology and Allergy, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden., Sörensson P; Department of Medicine, Solna, Karolinska Institutet, Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden., Y-Hassan S; Coronary Artery Disease Area, Heart and Vascular Theme, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden., Hofman-Bang C; Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine, Karolinska Institutet, Stockholm, Sweden., Tornvall P; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.

Publikováno v: Journal of internal medicine [J Intern Med] 2022 Mar; Vol. 291 (3), pp. 327-337. Date of Electronic Publication: 2021 Nov 24.

Zobrazit plný text záznamu

Akademický článek

Altered Vascular Reactivity to Circulating Angiotensin II in Familial Hypercholesterolemia.

Autor: Ekholm M; Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Division of Cardiovascular Medicine, Stockholm, Sweden., Wallén HN; Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Division of Cardiovascular Medicine, Stockholm, Sweden.; Department of Cardiology, Danderyd University Hospital Corp, Stockholm, Sweden., Brinck J; Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.; Theme Endocrinology and Nephrology, Karolinska University Hospital, Stockholm, Sweden; and., Jörneskog G; Department of Clinical Sciences, Danderyd Hospital, Division of Medicine, Stockholm, Sweden., Kahan T; Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Division of Cardiovascular Medicine, Stockholm, Sweden.; Department of Cardiology, Danderyd University Hospital Corp, Stockholm, Sweden.

Publikováno v: Journal of cardiovascular pharmacology [J Cardiovasc Pharmacol] 2021 Oct 01; Vol. 78 (4), pp. 551-559.

Zobrazit plný text záznamu

Akademický článek

Use of proteomics to identify biomarkers associated with chronic kidney disease and long-term outcomes in patients with myocardial infarction.

Autor: Edfors R; From the, Department of Clinical Sciences, Division of Cardiovascular Medicine, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.; Bayer AB, Solna, Sweden., Lindhagen L; Uppsala Clinical Research Center, Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Spaak J; From the, Department of Clinical Sciences, Division of Cardiovascular Medicine, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden., Evans M; Department of Clinical Science, Intervention and Technology (CLINTEC), Division of Renal Medicine, Karolinska Institutet, Stockholm, Sweden., Andell P; Department of Medicine, Unit of Cardiology, Karolinska Institutet, Stockholm, Sweden., Baron T; Uppsala Clinical Research Center, Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Mörtberg J; Department of Clinical Sciences, Division of Renal Medicine, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden., Rezeli M; Department of Biomedical Engineering, Lund University, Lund, Sweden., Salzinger B; Department of Clinical Sciences, Division of Renal Medicine, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden., Lundman P; From the, Department of Clinical Sciences, Division of Cardiovascular Medicine, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden., Szummer K; Department of Medicine, Unit of Cardiology, Karolinska Institutet, Stockholm, Sweden., Tornvall P; Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden., Wallén HN; From the, Department of Clinical Sciences, Division of Cardiovascular Medicine, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden., Jacobson SH; Department of Clinical Sciences, Division of Renal Medicine, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden., Kahan T; From the, Department of Clinical Sciences, Division of Cardiovascular Medicine, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden., Marko-Varga G; Department of Biomedical Engineering, Lund University, Lund, Sweden., Erlinge D; Department of Cardiology, Clinical Sciences, Lund University, Lund, Sweden., James S; Uppsala Clinical Research Center, Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Lindahl B; Uppsala Clinical Research Center, Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Jernberg T; From the, Department of Clinical Sciences, Division of Cardiovascular Medicine, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.

Publikováno v: Journal of internal medicine [J Intern Med] 2020 Nov; Vol. 288 (5), pp. 581-592. Date of Electronic Publication: 2020 Jul 08.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání